Regional Delivery Grant supports oligonucleotide researchers through regional meetings that build research communities, share knowledge, and foster networking and professional development.
Funder: Oligonucleotide Therapeutics Society
Due Dates: October 15, 2026 (Annual review deadline) | Rolling (Applications)
Funding Amounts: Up to $50,000 USD per grant; event and fund use within 18 months of funding
Summary: Supports regional oligonucleotide research meetings that broaden OTS’s reach and provide networking and professional development opportunities.
Key Information: The primary applicant must be a current OTS member, organizing a meeting outside the United States, Canada, and Europe.
The Oligonucleotide Therapeutics Society (OTS) Regional Delivery Grant supports new and established regional meetings and conferences serving oligonucleotide researchers. The program aims to broaden the society’s reach, build regional oligonucleotide communities, and encourage knowledge sharing, networking, and professional development. Supported meetings bring together participants from different laboratories, institutions, and companies, including students and junior researchers.
Funding supports meeting production rather than laboratory research. Alongside financial support, events receive an OTS calendar listing, mentoring, and assistance recruiting oligonucleotide experts as speakers. The regional outreach call identifies Australia/New Zealand, the Middle East, South Korea, and South America as regions of interest for expansion in 2026–2027.